UniProt ID | MYBA_HUMAN | |
---|---|---|
UniProt AC | P10243 | |
Protein Name | Myb-related protein A {ECO:0000303|PubMed:7987850, ECO:0000303|PubMed:8058310} | |
Gene Name | MYBL1 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 752 | |
Subcellular Localization | Nucleus . | |
Protein Description | Transcription factor that specifically recognizes the sequence 5'-YAAC[GT]G-3'. [PubMed: 8058310] | |
Protein Sequence | MAKRSRSEDEDDDLQYADHDYEVPQQKGLKKLWNRVKWTRDEDDKLKKLVEQHGTDDWTLIASHLQNRSDFQCQHRWQKVLNPELIKGPWTKEEDQRVIELVQKYGPKRWSLIAKHLKGRIGKQCRERWHNHLNPEVKKSSWTEEEDRIIYEAHKRLGNRWAEIAKLLPGRTDNSIKNHWNSTMRRKVEQEGYLQDGIKSERSSSKLQHKPCAAMDHMQTQNQFYIPVQIPGYQYVSPEGNCIEHVQPTSAFIQQPFIDEDPDKEKKIKELEMLLMSAENEVRRKRIPSQPGSFSSWSGSFLMDDNMSNTLNSLDEHTSEFYSMDENQPVSAQQNSPTKFLAVEANAVLSSLQTIPEFAETLELIESDPVAWSDVTSFDISDAAASPIKSTPVKLMRIQHNEGAMECQFNVSLVLEGKKNTCNGGNSEAVPLTSPNIAKFSTPPAILRKKRKMRVGHSPGSELRDGSLNDGGNMALKHTPLKTLPFSPSQFFNTCPGNEQLNIENPSFTSTPICGQKALITTPLHKETTPKDQKENVGFRTPTIRRSILGTTPRTPTPFKNALAAQEKKYGPLKIVSQPLAFLEEDIREVLKEETGTDLFLKEEDEPAYKSCKQENTASGKKVRKSLVLDNWEKEESGTQLLTEDISDMQSENRFTTSLLMIPLLEIHDNRCNLIPEKQDINSTNKTYTLTKKKPNPNTSKVVKLEKNLQSNCEWETVVYGKTEDQLIMTEQARRYLSTYTATSSTSRALIL | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
5 | Phosphorylation | ---MAKRSRSEDEDD ---CCCCCCCCCCCC | 39.18 | 25159151 | |
7 | Phosphorylation | -MAKRSRSEDEDDDL -CCCCCCCCCCCCCC | 51.12 | 25159151 | |
16 | Phosphorylation | DEDDDLQYADHDYEV CCCCCCCCCCCCCCC | 22.69 | 28985074 | |
21 | Phosphorylation | LQYADHDYEVPQQKG CCCCCCCCCCCHHHC | 18.53 | 27642862 | |
79 | Ubiquitination | QCQHRWQKVLNPELI CCHHHHHHHHCHHHH | 41.55 | 21890473 | |
79 | Ubiquitination | QCQHRWQKVLNPELI CCHHHHHHHHCHHHH | 41.55 | 21890473 | |
87 | Ubiquitination | VLNPELIKGPWTKEE HHCHHHHCCCCCHHH | 72.11 | - | |
92 | Ubiquitination | LIKGPWTKEEDQRVI HHCCCCCHHHHHHHH | 56.06 | - | |
104 | Ubiquitination | RVIELVQKYGPKRWS HHHHHHHHHCHHHHH | 44.70 | 21890473 | |
104 | Ubiquitination | RVIELVQKYGPKRWS HHHHHHHHHCHHHHH | 44.70 | 21890473 | |
108 | Ubiquitination | LVQKYGPKRWSLIAK HHHHHCHHHHHHHHH | 63.24 | - | |
138 | Sumoylation | NHLNPEVKKSSWTEE HHCCHHHHHCCCCHH | 45.32 | - | |
138 | Ubiquitination | NHLNPEVKKSSWTEE HHCCHHHHHCCCCHH | 45.32 | - | |
138 | Sumoylation | NHLNPEVKKSSWTEE HHCCHHHHHCCCCHH | 45.32 | - | |
166 | Ubiquitination | NRWAEIAKLLPGRTD CHHHHHHHHCCCCCC | 57.10 | - | |
199 | Sumoylation | GYLQDGIKSERSSSK CCCHHCCCCCCCCCC | 52.36 | 28112733 | |
199 | Ubiquitination | GYLQDGIKSERSSSK CCCHHCCCCCCCCCC | 52.36 | - | |
394 | Acetylation | PIKSTPVKLMRIQHN CCCCCCEEEEEEECC | 37.46 | 19608861 | |
418 | Acetylation | VSLVLEGKKNTCNGG EEEEEECCCCCCCCC | 33.21 | 25953088 | |
433 | Phosphorylation | NSEAVPLTSPNIAKF CCCCCCCCCCCHHHC | 35.75 | 25627689 | |
434 | Phosphorylation | SEAVPLTSPNIAKFS CCCCCCCCCCHHHCC | 24.51 | 25850435 | |
441 | Phosphorylation | SPNIAKFSTPPAILR CCCHHHCCCCHHHHH | 39.02 | 22210691 | |
442 | Phosphorylation | PNIAKFSTPPAILRK CCHHHCCCCHHHHHH | 36.10 | 27050516 | |
458 | Phosphorylation | RKMRVGHSPGSELRD CCCCCCCCCCCCCCC | 25.65 | 30266825 | |
461 | Phosphorylation | RVGHSPGSELRDGSL CCCCCCCCCCCCCCC | 36.52 | 27732954 | |
477 | Acetylation | DGGNMALKHTPLKTL CCCCCCCCCCCCCCC | 35.57 | 25953088 | |
479 | Phosphorylation | GNMALKHTPLKTLPF CCCCCCCCCCCCCCC | 28.82 | 27251275 | |
521 | Phosphorylation | CGQKALITTPLHKET CCCEEEEECCCCCCC | 24.18 | 30266825 | |
522 | Phosphorylation | GQKALITTPLHKETT CCEEEEECCCCCCCC | 19.50 | 30266825 | |
541 | Phosphorylation | KENVGFRTPTIRRSI HCCCCCCCHHHHHHH | 23.63 | 23312004 | |
543 | Phosphorylation | NVGFRTPTIRRSILG CCCCCCHHHHHHHCC | 26.88 | 23312004 | |
547 | Phosphorylation | RTPTIRRSILGTTPR CCHHHHHHHCCCCCC | 16.59 | 22199227 | |
551 | Phosphorylation | IRRSILGTTPRTPTP HHHHHCCCCCCCCCC | 30.13 | 22199227 | |
552 | Phosphorylation | RRSILGTTPRTPTPF HHHHCCCCCCCCCCC | 14.69 | 22199227 | |
555 | Phosphorylation | ILGTTPRTPTPFKNA HCCCCCCCCCCCCHH | 32.49 | 22199227 | |
557 | Phosphorylation | GTTPRTPTPFKNALA CCCCCCCCCCCHHHH | 40.52 | 9417069 | |
560 | Acetylation | PRTPTPFKNALAAQE CCCCCCCCHHHHHHH | 42.38 | 25953088 | |
592 | Sumoylation | EDIREVLKEETGTDL HHHHHHHHHHHCCCC | 59.69 | 28112733 | |
602 | Sumoylation | TGTDLFLKEEDEPAY HCCCCEECCCCCHHH | 52.29 | 28112733 | |
602 | Sumoylation | TGTDLFLKEEDEPAY HCCCCEECCCCCHHH | 52.29 | - | |
617 | Phosphorylation | KSCKQENTASGKKVR HHHCCCCCCCCCCCH | 22.81 | 28555341 | |
619 | Phosphorylation | CKQENTASGKKVRKS HCCCCCCCCCCCHHH | 49.45 | 28555341 | |
621 | Acetylation | QENTASGKKVRKSLV CCCCCCCCCCHHHHH | 45.67 | 30586621 | |
626 | Phosphorylation | SGKKVRKSLVLDNWE CCCCCHHHHHHCCCC | 17.10 | 22199227 | |
643 | Phosphorylation | ESGTQLLTEDISDMQ CHHCEEEECCHHHHH | 39.96 | 24043423 | |
647 | Phosphorylation | QLLTEDISDMQSENR EEEECCHHHHHCCCC | 39.08 | 24043423 | |
651 | Phosphorylation | EDISDMQSENRFTTS CCHHHHHCCCCCCCH | 30.15 | 24043423 | |
678 | Acetylation | RCNLIPEKQDINSTN CCCCCCCCCCCCCCC | 48.17 | 26051181 | |
683 | Phosphorylation | PEKQDINSTNKTYTL CCCCCCCCCCCEEEE | 33.42 | 29978859 | |
684 | Phosphorylation | EKQDINSTNKTYTLT CCCCCCCCCCEEEEE | 35.92 | 29978859 | |
686 | Ubiquitination | QDINSTNKTYTLTKK CCCCCCCCEEEEEEC | 42.89 | - | |
687 | Phosphorylation | DINSTNKTYTLTKKK CCCCCCCEEEEEECC | 24.65 | 29978859 | |
688 | Phosphorylation | INSTNKTYTLTKKKP CCCCCCEEEEEECCC | 11.02 | 29978859 | |
689 | Phosphorylation | NSTNKTYTLTKKKPN CCCCCEEEEEECCCC | 32.93 | 29978859 | |
691 | Phosphorylation | TNKTYTLTKKKPNPN CCCEEEEEECCCCCC | 32.77 | 29978859 | |
704 | Acetylation | PNTSKVVKLEKNLQS CCHHHHEEEHHHHHH | 54.65 | 20167786 | |
743 | Phosphorylation | YLSTYTATSSTSRAL HHHHHCCCCCCCCEE | 18.53 | 28555341 | |
745 | Phosphorylation | STYTATSSTSRALIL HHHCCCCCCCCEECC | 26.50 | 68696077 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
7 | S | Phosphorylation | Kinase | CSNK2A1 | P68400 | GPS |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of MYBA_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of MYBA_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
NUCL_HUMAN | NCL | physical | 10660576 | |
LIN9_HUMAN | LIN9 | physical | 28514442 | |
LIN52_HUMAN | LIN52 | physical | 28514442 | |
LIN54_HUMAN | LIN54 | physical | 28514442 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-394, AND MASS SPECTROMETRY. |